中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2008年
5期
732-733
,共2页
葛秋生%陈金玉%徐颂周%林玉娟
葛鞦生%陳金玉%徐頌週%林玉娟
갈추생%진금옥%서송주%림옥연
哮喘%抗哮喘药%糖皮质激素%肾上腺素能β激动剂%儿童
哮喘%抗哮喘藥%糖皮質激素%腎上腺素能β激動劑%兒童
효천%항효천약%당피질격소%신상선소능β격동제%인동
Asthma%Anti-asthmatic agents%Glucocorticoids%Adrenergic beta-agonists%Child
目的 观察沙美特罗替卡松(SM/FP)干粉剂吸入治疗儿童哮喘的疗效.方法 根据患儿治疗前哮喘的严重程度给予不同剂量SM/FP吸入,应用该药治疗180d以上,评价7d、30d、180d的疗效.结果 经过SM/FP 180d吸入治疗,显著提高了哮喘患儿的晨间最大呼气流速值、夜间最大呼气流速值,明显改善了患儿的肺功能;亦显示SM/FP能够改善患儿日夜间哮喘症状评分,减缓哮喘症状,可减少短效β2受体激动剂的使用.同时证实,在治疗第1周上述疗效指标即有显著的改善,且在治疗半年后得到持续改善.结论 沙美特罗替卡松干粉剂吸入治疗小儿哮喘效果显著,值得推广应用.
目的 觀察沙美特囉替卡鬆(SM/FP)榦粉劑吸入治療兒童哮喘的療效.方法 根據患兒治療前哮喘的嚴重程度給予不同劑量SM/FP吸入,應用該藥治療180d以上,評價7d、30d、180d的療效.結果 經過SM/FP 180d吸入治療,顯著提高瞭哮喘患兒的晨間最大呼氣流速值、夜間最大呼氣流速值,明顯改善瞭患兒的肺功能;亦顯示SM/FP能夠改善患兒日夜間哮喘癥狀評分,減緩哮喘癥狀,可減少短效β2受體激動劑的使用.同時證實,在治療第1週上述療效指標即有顯著的改善,且在治療半年後得到持續改善.結論 沙美特囉替卡鬆榦粉劑吸入治療小兒哮喘效果顯著,值得推廣應用.
목적 관찰사미특라체잡송(SM/FP)간분제흡입치료인동효천적료효.방법 근거환인치료전효천적엄중정도급여불동제량SM/FP흡입,응용해약치료180d이상,평개7d、30d、180d적료효.결과 경과SM/FP 180d흡입치료,현저제고료효천환인적신간최대호기류속치、야간최대호기류속치,명현개선료환인적폐공능;역현시SM/FP능구개선환인일야간효천증상평분,감완효천증상,가감소단효β2수체격동제적사용.동시증실,재치료제1주상술료효지표즉유현저적개선,차재치료반년후득도지속개선.결론 사미특라체잡송간분제흡입치료소인효천효과현저,치득추엄응용.
Objective To observe the effect of salmeterol/flutieasone propionate on children with asthma. Methods Salmeterol/flutieasone propionate inhalation of different dosages were given according to different illness condition of asthma. Investigate the effects of 180 days inhalation of SM/FP among children. Results After 180 days' treatment, the PEFam and PEFpm of those children of asthma were significantly increased. The lung function has a perceptible improvement. In addition, the daytime and noctural symptom scores and asthma symptom were improved. Moreover, the shore-acting β2 agonist was used with decreasing frequency. The effects of SM/FP inhalation were marvelous after 1 week of treatment and should make a long persisting time alter six months of treatment. Conclusion SM/FP is an effective medicine for children with asthma and should be make more widespread.